Alexandre Bazinet

BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome

Alejandro Estrada‐Cuzcano, Robert K. Koenekoop, Audrey Sénéćhal et al. · Archives of Ophthalmology · 2012 · 126 citations

Life Sciences, Genetics, Ophthalmology +12

Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study

Alexandre Bazinet, Faezeh Darbaniyan, Elias Jabbour et al. · The Lancet Haematology · 2022 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +15

Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax

Álex Bataller, Alexandre Bazinet, Courtney D. DiNardo et al. · Blood Advances · 2023 · 78 citations · Full text

Medicine, Oncology, Pharmacology +13

A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing

Jacek Majewski, S. Al Humaid, Julie Racine et al. · Journal of Medical Genetics · 2011 · 48 citations

Medicine, Genetics, Molecular Genetics +14

Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up

Philip A. Thompson, Alexandre Bazinet, William G. Wierda et al. · Blood · 2023 · 47 citations · Full text

Medicine, Internal Medicine, Immunotherapy +13